Outcome of gemcitabine plus molecular targeted agent for treatment of pancreatic cancer: a meta-analysis of prospective phase III studies
Crossref DOI link: https://doi.org/10.1007/s13277-014-2451-6
Published Online: 2014-08-17
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Lin
Zhang, Ming
Luo, Shuchun
Text and Data Mining valid from 2014-08-17